Multinational clinical studies surpass Korea’s domestic trials in 2009

The number of multinational clinical trials conducted by multinational pharmaceutical companies in Korea was 202 last year, which exceeded that of trials by domestic firms (198) last year, reflecting the rapid development of the local clinical experimentation sector, the nation's drug watchdog said on February 9.

A KFDA official said the majority of foreign and domestic clinical studies have...